Haemorrhage control in severely injured patients (Q34642910)

3 August 2017

Haemorrhage control in severely injured patients (English)

1 reference

3 August 2017

0 references

Russell L Gruen

1

1 reference

3 August 2017

Karim Brohi

2

1 reference

3 August 2017

Martin Schreiber

3

1 reference

3 August 2017

Zsolt J Balogh

4

1 reference

3 August 2017

Veronica Pitt

5

1 reference

3 August 2017

Mayur Narayan

6

1 reference

3 August 2017

Ronald V Maier

7

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 September 2012

1 reference

3 August 2017

1 reference

3 August 2017

380

1 reference

3 August 2017

9847

1 reference

3 August 2017

1099-1108

1 reference

Impact of hemorrhage on trauma outcome: an overview of epidemiology, clinical presentations, and therapeutic considerations

3 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

The beginning of the end for damage control surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

Microcirculatory responses to hypovolemic shock.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

Damage control resuscitation: the new face of damage control

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

Ischemia/reperfusion injury: The role of immune cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

Persistent inflammation and immunosuppression: a common syndrome and new horizon for surgical intensive care

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

A genomic storm in critically injured humans

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

Dissecting inflammatory complications in critically injured patients by within-patient gene expression changes: a longitudinal clinical genomics study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

Prehospital tourniquet use in Operation Iraqi Freedom: effect on hemorrhage control and outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

Practical use of emergency tourniquets to stop bleeding in major limb trauma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

A comprehensive review of topical hemostatic agents: efficacy and recommendations for use.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

Pre-hospital haemostatic dressings: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

Update on the roles of angiography and embolisation in pelvic fracture

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

Angioembolization provides benefits in patients with concomitant unstable pelvic fracture and unstable hemodynamics

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

Preperitoneal pelvic packing/external fixation with secondary angioembolization: optimal care for life-threatening hemorrhage from unstable pelvic fractures.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

Hepatic arterial embolization in the management of blunt hepatic trauma: indications and complications

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

Nonoperative management of adult blunt splenic injury with and without splenic artery embolotherapy: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

Acute traumatic coagulopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

Definition and drivers of acute traumatic coagulopathy: clinical and experimental investigations.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

Acute coagulopathy and early deaths post major trauma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

The coagulopathy of trauma: a review of mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

Drivers of acute coagulopathy after severe trauma: a multivariate analysis of 1987 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

Acute coagulopathy of trauma: hypoperfusion induces systemic anticoagulation and hyperfibrinolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

Critical role of activated protein C in early coagulopathy and later organ failure, infection and death in trauma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

Acute traumatic coagulopathy: initiated by hypoperfusion: modulated through the protein C pathway?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

Early coagulopathy in trauma patients: an on-scene and hospital admission study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

Treating coagulopathy in trauma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

Clotting factor deficiency in early trauma-associated coagulopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

Fibrinogen levels during trauma hemorrhage, response to replacement therapy, and association with patient outcomes.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

Fibrinogen availability and coagulation function after hemorrhage and resuscitation in pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

Early coagulopathy in multiple injury: an analysis from the German Trauma Registry on 8724 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

The Effect of Temperature and pH on the Activity of Factor VIIa: Implications for the Efficacy of High-Dose Factor VIIa in Hypothermic and Acidotic Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

Coagulopathy by hypothermia and acidosis: mechanisms of thrombin generation and fibrinogen availability

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

Coagulation changes to systemic acidosis and bicarbonate correction in swine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

Coagulopathy in trauma patients: importance of thrombocyte function?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

Early platelet dysfunction: an unrecognized role in the acute coagulopathy of trauma.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

Acutely injured patients on dabigatran

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

Changes in massive transfusion over time: an early shift in the right direction?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

Plasma/platelets/red blood cell ratio in the management of the bleeding traumatized patient: does it matter?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

Use of freeze-dried plasma in French intensive care unit in Afghanistan

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

Lyophilized plasma for resuscitation in a swine model of severe injury

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

A high ratio of plasma and platelets to packed red blood cells in the first 6 hours of massive transfusion improves outcomes in a large multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

The impact of platelet transfusion in massively transfused trauma patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

The ratio of fibrinogen to red cells transfused affects survival in casualties receiving massive transfusions at an army combat support hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

Prevalence of survivor bias in observational studies on fresh frozen plasma:erythrocyte ratios in trauma requiring massive transfusion.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

Crystalloid to packed red blood cell transfusion ratio in the massively transfused patient: when a little goes a long way.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

Transfusion in trauma: thromboelastometry-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma-based therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

Fibrinogen concentrates for bleeding trauma patients: what is the evidence?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: two parallel randomized, placebo-controlled, double-blind clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

Results of the CONTROL trial: efficacy and safety of recombinant activated Factor VII in the management of refractory traumatic hemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

Factor IX complex for the correction of traumatic coagulopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

Evaluation of rotation thrombelastography for the diagnosis of hyperfibrinolysis in trauma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

The cellular, metabolic, and systemic consequences of aggressive fluid resuscitation strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

Early use of vasopressors after injury: caution before constriction.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

Early vasopressor use in critical injury is associated with mortality independent from volume status.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

Targeted resuscitation improves coagulation and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

Hypertonic resuscitation modulates the inflammatory response in patients with traumatic hemorrhagic shock.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

Hypertonic versus near isotonic crystalloid for fluid resuscitation in critically ill patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

Hypertonic resuscitation of hypovolemic shock after blunt trauma: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

Out-of-hospital hypertonic resuscitation after traumatic hypovolemic shock: a randomized, placebo controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

Colloid solutions for fluid resuscitation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

Human albumin solution for resuscitation and volume expansion in critically ill patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

Colloids versus crystalloids for fluid resuscitation in critically ill patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

Warm fresh whole blood is independently associated with improved survival for patients with combat-related traumatic injuries

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

Randomized, prospective trial of antioxidant supplementation in critically ill surgical patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

Reduction of resuscitation fluid volumes in severely burned patients using ascorbic acid administration: a randomized, prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

Lyophilized plasma with ascorbic acid decreases inflammation in hemorrhagic shock.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

Lyophilized plasma reconstituted with ascorbic acid suppresses inflammation and oxidative DNA damage

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

Antifibrinolytic therapy: new data and new concepts

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

Attenuating burn wound inflammation improves pulmonary function and survival in a burn-pneumonia model

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

Hypothermia to reduce neurological damage following coronary artery bypass surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

Hypothermia for traumatic head injury

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

Translational barriers and opportunities for emergency preservation and resuscitation in severe injuries

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

Aggressive fresh frozen plasma (FFP) with massive blood transfusion in the absence of acute traumatic coagulopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

Multicenter validation of a simplified score to predict massive transfusion in trauma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

A predictive model for massive transfusion in combat casualty patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

Early prediction of acute traumatic coagulopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

Functional definition and characterization of acute traumatic coagulopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

The importance of early treatment with tranexamic acid in bleeding trauma patients: An exploratory analysis of the CRASH-2 randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

Emerging treatment strategies for trauma-induced coagulopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961224-0

7 January 2021

10.1016/S0140-6736(12)61224-0

Identifiers

DOI

1 reference

3 August 2017

1 reference